This page includes the latest FDA filings for Chemocentryx Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| USA | NASDAQ | CCXI | DUNS 002356900 |
Device Company | Device | Date |
|---|---|---|
| ChemoCentryx, Inc. | Prescription Medication | 2025-06-28 |
| ChemoCentryx, Inc. | Prescription Medication | 2024-12-15 |
| ChemoCentryx, Inc. | Prescription Medication | 2024-11-13 |
| ChemoCentryx, Inc. | Prescription Medication | 2024-06-19 |
| ChemoCentryx, Inc. | Prescription Medication | 2023-12-19 |
| ChemoCentryx, Inc. | Prescription Medication | 2023-10-24 |
| ChemoCentryx, Inc. | Prescription Medication | 2022-02-16 |
| ChemoCentryx, Inc. | Prescription Medication | 2021-10-27 |
CHEMOCENTRYX, INC. | 2021-10-19 19:22:30 | |
| ChemoCentryx, Inc. | TAVNEOS | 2021-10-18 |
| ChemoCentryx, Inc. | Prescription Medication | 2021-10-18 |
| NCAGE Code | 1KMV4 | CHEMOCENTRYX, INC. |
| CAGE Code | 1KMV4 | CHEMOCENTRYX, INC. |
| S.A.M. Registration | 1KMV4 [2356900] | CHEMOCENTRYX, INC. |
| SEC | 0001340652 | ChemoCentryx, Inc. of DELAWARE |